Publisher
Springer Science and Business Media LLC
Subject
Neurology (clinical),Neurology
Reference15 articles.
1. Allain H, Destee A, Petit H, et al. (2000) Five-year follow-up of early lisuride and levodopa monotherapy in de novo Parkinson’s disease. The French Lisuride Study Group. Eur Neurol 44:22–30
2. Chapuis S, Ouchchane L, Metz O, Gerbaud L, Durif F (2005) Impact of motor complications of Parkinson’s disease on the quality of life. Mov Disord 20:224–230
3. Constantinescu R, Romer M, McDermott MP, Kamp C, Kieburtz K, CALMPD Investigators of the Parkinson Study Group (2007) Impact of pramipexole on the onset of levodopa-related dyskinesias. Mov Disord online in Wiley InterScience (www.interscience.wiley.com). DOI:10.1002/mds.21292
4. Dupont E, Andersen A, Boas J, et al. (1996) Sustained-release Madopar HBS compared with standard Madopar in the long-term treatment of de novo parkinsonian patients. Acta Neurol Scand 93:14–20
5. Efficacy and safety of carbiodopa/levodopa/entacapone in patients with Parkinson’s disease requiring initiation of levodopa therapy. Clinical Trials. Government Identifier NCT00099268
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献